News & Press Releases

Mintz has partnered with A Good Option (AGO), a nonprofit organization advancing an innovative equity-based approach to charitable giving. Through the firm's pro bono program, Mintz is advising AGO on governance, equity donation structures, and other legal and operational matters as the organization expands.

Mintz Partner Lee Johnson, PhD, has been named Patent Strategy Practitioner of the Year in the 2026 LMG Life Sciences Americas Awards. The firm also received the Impact Deal of the Year – Canada award for its representation of Kye Pharmaceuticals in its licensing and distribution agreement with Neurim Pharmaceuticals for SLENYTO® in Canada.

Michael Leib’s insights were featured in an IAM article discussing how several recent appointments to the US International Trade Commission may influence future investigations and commission precedent.

Michelle Capezza was featured in Fiduciary News discussing the administrative and fiduciary considerations associated with small-balance cashouts and automatic IRA rollovers in employer-sponsored retirement plans.

NEW YORK – Mintz welcomes Mark Shaffer to the firm's Investment Funds Practice as a Member based in New York. With more than 20 years of experience advising clients across the financial services ecosystem, including private funds, fintech companies, broker dealers, and digital asset businesses, Mark further strengthens Mintz's market-leading capabilities in financial regulation, compliance, and emerging technologies.

Mintz is advising the shareholders of ZuriMED Technologies AG on US law matters in connection with the company's proposed acquisition by Stryker. The shareholder group comprises more than 100 institutional and private investors.